Interleukin 12 (IL-12) activates natural killer (NK) and T cells with
the secondary synthesis and release of interferon-gamma (IFN-gamma) an
d other cytokines. IL-12-induced organ alterations are reported for mi
ce and the pathogenetic role of IFN-gamma is investigated by the use o
f mice deficient in the IFN-gamma receptor (IFN-gamma R(-/-)). IL-12 c
aused a rapid infiltration of liver and splenic red pulp with activate
d macrophages; this and increased NK cells resulted in a fivefold incr
ease of splenic weight in wild-type mice. Splenomegaly was associated
with myelosuppression and decreasing peripheral leukocyte counts. IL-1
2-induced changes in wild-type mice were associated with markedly incr
eased IFN-gamma serum levels and up-regulation of major histocompatibi
lity complex (MHC) class I and II expression in various epithelia. IL-
12 induced a qualitatively similar macrophage infiltration in IFN-gamm
a R(-/-) mice, less marked splenomegaly (to 2 x normal), and no MHC up
regulation. Strikingly increased vascular endothelial intercellular ad
hesion molecule-1 expression was apparent in both IFN-gamma R(-/-) and
IFN-gamma R(+/+) mice. Restricted to mutant mice was a severe, invari
ably lethal, interstitial, and perivascular pulmonary macrophage infil
tration with diffuse pulmonary edema. Extensive quantitative reverse t
ranscriptase polymerase chain reaction analysis revealed an increase o
f only IL-6 and IL-10 pulmonary gene transcripts in IFN-gamma R(-/-) m
ice compared with wild-type mice. IL-12-induced myelosuppression is du
e to IFN-gamma-release from NK cells and T cells, and is associated wi
th macrophage activation and distinct MHC class I and II antigen upreg
ulation. The pulmonary pathology in IFN-gamma R(-/-) mice, however, re
veals a toxic potential for IL-12 and suggests that endogenous IFN-gam
ma plays a protective role in preventing fatal pulmonary disease in th
ese mice.